1. Field of the Invention
The field of the invention generally relates to an aspiration system for removing, by aspiration, undesired matter such as a thrombus from a fluid carrying cavity, duct, or lumen of the body, such as a blood vessel.
2. Description of the Related Art
A treatment method for removing undesired matter such as thrombus from a blood vessel of a patient involves use of an aspiration catheter having elongate shaft formed with an aspiration lumen extending therein. An aspiration catheter may also include a guidewire lumen for placement of a guidewire, which is used to guide the aspiration catheter to a target site in the body. By applying a vacuum (i.e. negative pressure) to a proximal end of the aspiration lumen, for example, with a syringe having a hub that is connected to the proximal end of the aspiration catheter, the matter can be aspirated into an aspiration port at the distal end of the aspiration catheter, into the aspiration lumen, and thus be removed from the patient.
In one embodiment, a system for real time monitoring of catheter aspiration includes a vacuum source, an aspiration catheter having an aspiration lumen, a housing having a first port configured to couple to the vacuum source and a second port configured to couple to the aspiration lumen of the aspiration catheter, a pressure sensor in fluid communication with an interior of the housing, a measurement device coupled to the pressure sensor and configured for measuring deviations in fluid pressure, and a communication device coupled to the measurement device and configured to generate an alert when a deviation in fluid pressure measured by the measurement device exceeds a pre-set threshold.
In another embodiment, a system for real time monitoring of catheter aspiration includes a housing having a first port adapted for detachable connection to a vacuum source and a second port adapted for detachable connection with an aspiration catheter, a pressure sensor in fluid communication with an interior of the housing, a measurement device coupled to the pressure sensor and configured for measuring deviations in fluid pressure, and a communication device coupled to the measurement device and configured to generate an alert signal when a deviation in fluid pressure measured by the measurement device exceeds a pre-set threshold.
In another embodiment, a method for real time monitoring of catheter aspiration includes the steps of inserting an aspiration catheter having an aspiration lumen into a patient, providing a system for real time monitoring of catheter aspiration, the system including a housing having a first port adapted for detachable connection to a vacuum source and a second port adapted for detachable connection with the aspiration lumen of the aspiration catheter, a pressure sensor in fluid communication with an interior of the housing, a measurement device coupled to the pressure sensor and configured for measuring deviations in fluid pressure, and a communication device coupled to the measurement device and configured to generate an alert signal when a deviation in fluid pressure measured by the measurement device exceeds a pre-set threshold, coupling the first port to a vacuum source, coupling the second port to the aspiration lumen of the aspiration catheter, and causing or allowing a body fluid to be aspirated through the aspiration lumen of the aspiration catheter, wherein the measurement device measures fluid pressure during aspiration of the body fluid, and wherein the communication device generates an alert signal when one or more measured deviations in fluid pressure exceed a pre-set threshold during the aspiration of the body fluid.
The present invention relates to a monitoring, warning and communication system for aspiration catheter systems. Clogging of aspiration catheters, for example by large pieces of thrombus, is a common concern for users. Techniques to avoid clogging/choking of material within the catheter often involve rapidly, aggressively advancing the aspiration catheter or gently plucking at edges of a thrombus to insure only small pieces or portions are introduced at a time, pieces which are small enough to not clog or occlude the aspiration lumen. When a device becomes clogged during use, the potential for inadvertent dislodgment of thrombus downstream increases; this is referred to as distal embolism. As aspiration procedures of this type are often used in highly technical emergent settings, early clog detection of the aspiration catheter for the user during aspiration can contribute to the success of the procedure and clinical outcome. Some sources have reported that up to 50% of aspiration catheters used get clogged during use.
Additionally, the user may have difficulty determining whether there has been a loss of vacuum in the system, for example because of the syringe (or other vacuum source) being full of fluid or because of a leak in the system. Blood is relatively opaque and can coat the wall of the syringe, thus making it difficult to determine when the syringe becomes full. This makes it difficult to determine whether sufficient vacuum is being applied to the aspiration catheter. It is also difficult to determine whether there is an air leak in the system, which can be another cause for a loss of vacuum even before the syringe becomes full of the aspirated fluid.
During the aspiration of thrombus with an aspiration catheter, it is difficult to identify when thrombus is actively being aspirated, and when only blood is being aspirated. Typically it is desired to not aspirate sizable quantities of normal blood from blood vessels, because of the importance of maintaining normal blood volume and blood pressure. However, when tracking the tip of an aspiration catheter in proximity to a thrombus, it is difficult to know whether the aspiration catheter has actively engaged a thrombus, whether it has aspirated at least a portion of the thrombus, or whether it is not engaged with the thrombus, and is only aspirating blood. The use of aspiration catheters can therefore be inefficient, and cause more blood removal than desired, causing a user to minimize the length of the therapy and in severe cases necessitating blood transfusion. An increased volume of normal blood being aspirated also means that the vacuum source (e.g. syringe) will fill in a shorter amount of time, thus required more frequent replacement of the vacuum source. Distal embolism may occur if the vacuum pressure is not sufficient, and yet the user is not aware.
An aspiration system 2 is illustrated in
The pressure transducer 12 of the aspiration monitoring system 48 is configured to be fluidly coupled between the vacuum source band the aspiration catheter 4. In
For definition purposes, when speaking of the amount of vacuum, a pressure of, for example, −15,000 pascal (−2.18 pounds per square inch, or psi) is a “larger vacuum” than −10,000 pascal (−1.45 psi). Additionally, −15,000 pascal is a “lower pressure” than −10,000 pascal. Furthermore, −15,000 pascal has a larger “absolute vacuum pressure” than does −10,000 pascal, because the absolute value of −15,000 is larger than the absolute value of −10,000. In
One or more communication devices 58a, 58b, 58c are included within the aspiration monitoring system 48 and are coupled to the measurement device 54. Each of the one or more communication devices 58a-c are configured to generate a type of alert comprising an alert signal 60a-c, in response at least in part to activity and output of the measurement device 54. In some embodiments, the communication device 58a may include one or more LEDs (light emitting diodes) configured to generate a visible alert via a visible alert signal 60a, such as light that is continuously illuminated, or is illuminated in a blinking pattern. In some embodiments, lights other than LEDs may be used. In some embodiments, the communication device 58b may include one or more vibration generators configured to generate a tactile alert via a tactile alert signal 60b, which may include, but is not limited to, vibration or heat. In some embodiments, the vibration generator may comprise a piezoelectric device which is configured to vibrate when a voltage is applied. In some embodiments, the communication device 58c may include one or more sound generating devices configured to generate an audible alert via an audible alert signal 60c, such as a continuous noise, or a repeating noise. In some embodiments, the sound generating device may comprise a buzzer which is configured to sound one or more audible pitches when a voltage is applied. In some embodiments a piezoelectric device, such as that described in relation to the communication device 58b may also serve as a sound generating device, included as communication device 58c.
A user of an aspiration system 2 may desire to be notified of several conditions which may occur during use of the aspiration system 2. These potential conditions include, but are not limited to clogging, a loss of vacuum due to filling of the vacuum source 6 and or a breach, break or puncture in the aspiration system 2, and the engagement or aspiration of non-fluid, solid or semi-solid material such as thrombus. The aspiration monitoring system 48 of
The pressure transducer 12 of the aspiration monitoring system 48 is configured to continuously measure and monitor the absolute pressure amplitude within the closed system of the aspiration system 2, and also is configured to measure and monitor the relative pressure over time to detect noteworthy flow changes within the flow circuit of the aspiration system 2. Some changes are discernible via absolute pressure measurement, while more subtle pressure deflections may be compared to a stored library in memory. Noteworthy conditions may be signaled to the user when appropriate. In some embodiments, the unfiltered signal may be amplified by an amplifier and filtered by a filter, for example, to increase the signal-to-noise ratio. Examples of the (background) noise 57 in an unfiltered signal can be seen in
In some embodiments, the communication device 68 may be wearable by the user.
The measurement device 54, 64 is configured to compare the curve 97 with information stored in the memory module 56, 66 to identify this condition. In some embodiments, the measurement device 54, 64 uses an algorithm to make the comparison. In some embodiments, the measurement device 54, 64 then sends a signal to the communication device 58a-c, 74, and the communication device 58a-c, 74 generates an appropriate alert. Communication device 58a, for example a particular color LED, may be illuminated, or an LED may flash in a particular pattern or number of flashes. Communication device 58b may create a characteristic sound, or may generate an audio message in a number of languages. For example, the audio message may state, “Thrombus encountered,” or “No thrombus encountered.” Communication device 58c may vibrate or heat in a characteristic pattern, for example, a certain number of repetitions or a certain frequency between repetitions. The user may determine that an additional fluoroscopic image (e.g. angiography) or other imaging modalities may be necessary to better identify the location of the thrombus 88.
The measurement device 54, 64 is configured to compare the curve 93 with information stored in the memory module 56, 66 to identify this condition. In some embodiments, the measurement device 54, 64 uses an algorithm to make the comparison. In some embodiments, a pre-set pressure differential ΔP1 may be stored in the memory module 56, 66 as a threshold, whereby the measurement of a pressure difference 81 less than this threshold does not result in the measurement device 54, 64 commanding the communication device 58a-c, 74 to send an alert signal 60a-c, 70. In some embodiments, when the pressure difference 81 is greater than (or greater than or equal to) the pre-set pressure differential ΔP1, the measurement device 54, 64 then sends a signal to the communication device 58a-c, 74, and the communication device 58a-c, 74 generates an appropriate alert. Communication device 58a, for example a particular color LED, may be illuminated, or an LED may flash in a particular pattern or number of flashes. Communication device 58b may create a characteristic sound, or may generate an audio message in a number of languages. For example, the audio message may state, “Clog Condition.” Communication device 58c may vibrate or heat in a characteristic pattern, for example, a certain number of repetitions or a certain frequency between repetitions. When the user realizes that the clog condition is present, the user may pull on the aspiration catheter 4 and readvance it, in an attempt to contact a portion of the thrombus 88 that can be aspirated. If a portion of the thrombus is clogged in the aspiration lumen 18, and repositioning of the aspiration catheter 4 does not produce good results, the aspiration catheter 4 can be removed and the aspiration system 2 can be repurged, for example by a positive pressurization.
The measurement device 54, 64 is configured to compare the curve 85 with information stored in the memory module 56, 66 to identify this condition. In some embodiments, the measurement device 54, 64 uses an algorithm to make the comparison. In some embodiments, the measurement device 54, 64 then sends a signal to the communication device 58a-c, 74, and the communication device 58a-c, 74 generates an appropriate alert. Communication device 58a, for example a particular color LED, may be illuminated, or an LED may flash in a particular pattern or number of flashes. Communication device 58b may create a characteristic sound, or may generate an audio message in a number of languages. For example, the audio message may state, “System Leak.” Communication device 58c may vibrate or heat in a characteristic pattern, for example, a certain number of repetitions or a certain frequency between repetitions. Upon receiving the alert, the user will check the components of the aspiration system 2 and either fix the breach or replace one or more of the components of the aspiration system 2. For example, in some cases, the communication device 58a-c, 74 may alert the user when the measurement device 54, 64 confirms a loss of vacuum, allowing the user to change or recharge the vacuum source 6, which has become depleted (e.g. by filling with blood and/or thrombus).
The measurement device 54, 64 is configured to compare the curve 79 with information stored in the memory module 56, 66 to identify when the pieces or portions 90 of thrombus 88 are actively being aspirated, as in deviation 77 and deviation 73, and when the pieces or portions of thrombus 88 are not being actively, or substantially, aspirated, as in steady pressure curve 97, the steady pressure curve 75, and the steady pressure curve 71. In some embodiments, the measurement device 54, 64 uses an algorithm to make the comparison. In some embodiments, a pre-set pressure differential ΔP2 may be stored in the memory module 56, 66 as a threshold, whereby the measurement of a pressure difference 69 less than this threshold does not result in the measurement device 54, 64 commanding the communication device 58a-c, 74 to send a first type of alert via an alert signal 60a-c, 70. In some embodiments, when the pressure difference 69 is greater than (or greater than or equal to) the pre-set pressure differential ΔP2, the measurement device 54, 64 then sends a signal to the communication device 58a-c, 74, and the communication device 58a-c, 74 generates an appropriate alert. Communication device 58a, for example a particular color LED, may be illuminated, or an LED may flash in a particular pattern or number of flashes. In some embodiments, the communication device 58a may comprise a light whose intensity increases proportionally with the pressure. Communication device 58b may create a characteristic sound, or may generate an audio message in a number of languages. For example, the audio message may state, “Thrombus being aspirated.” In some embodiments, communication device 58b may comprise one or more noises or beeps. In some embodiments, the communication device 58b may comprise a particular series of beeps corresponding to each different condition. For example, three short beeps may correspond to no thrombus being aspirated, while five long, loud beeps may correspond to a system leak. In some embodiments, a plurality of different tones (pitches) may be used to alert a user about different conditions. As an example, a low pitch sound may be used for a first condition (e.g. no thrombus being aspirated) and a second, higher pitch sound may be used for a second condition (e.g. a system leak). In some embodiments, a plurality of different tones may be used to alert a user about a first condition and a second plurality (e.g. in a different combination, or with additional tones) may be used to alert a user about a second condition. Communication device 58c may vibrate or heat in a characteristic pattern, for example, a certain number of repetitions or a certain frequency between repetitions. When the user realizes that the thrombus is being aspirated, the user may choose to advance (or retract) the aspiration catheter 4, for example with fluoroscopic visualization, along the length of the thrombus 88, in an attempt to continue the aspiration of the thrombus 88. In some cases, the user may choose to stop the advancement or retraction of the aspiration catheter 4 at a certain amount of time after the alert is generated, in order to allow the pieces or portions 90 of thrombus 88 to completely exit the aspiration lumen 18. When the measurement device 54, 64 identifies a subsequent steady pressure curve 75, 71 that follows a deviation 77, 73, the measurement device 54, 64 in some embodiments sends a signal that causes the communication device 58a-c, 74 to generate a second type of alert via an alert signal 60a-c, 70. For example, in some embodiments, communication device 58b may send an audio message that states, “Thrombus no longer being aspirated.” When the user realizes that the thrombus is no longer being aspirated, the user may advance or retract the aspiration catheter, in an attempt to contact another portion of the thrombus 88 that can be aspirated. In some embodiments, the deviation 77 may be positively identified as a true deviation indicating thrombus being actively aspirated, pressure difference 69 is between about 700 pascal and about 1700 pascal. In some embodiments, the deviation 77 may be positively identified as a true deviation indicating thrombus being actively aspirated, pressure difference 69 is between about 1000 pascal and about 1300 pascal. In some embodiments, the deviation 77 may be positively identified as a true deviation indicating thrombus being actively aspirated, pressure difference 69 is about 1138 pascal. The pressure difference 69 may be measured by determining a baseline pressure 63 and a peak pressure 61 and determining the absolute value difference. For example:
Absolute value difference (AVD)=|(−89,631 pascal)−(−90,769 pascal)|=1138 pascal
Or for example:
Absolute value difference (AVD)=|(−43,710 pascal)−(−45,102 pascal)|=1281 pascal
The pressure difference 81 (
Because vacuum pressure is a negative pressure, the peak pressure 61, as shown in
Insertion of the pressure transducer 12 in line in either the embodiment of
In some embodiments, instead of an LED, the visual alert is provided by a communication device 58a comprising a display which displays visual messages of text in a particular language, for example, “Thrombus encountered,” “No thrombus encountered,” “Clog condition,” “System leak,” “Loss of vacuum,” “Thrombus being aspirated,” or “Thrombus no longer being aspirated.” The visual messages may be combined with any of the other alert signals 60a-c, 70 described herein. The aspiration monitoring system 48, 62, 78 described herein give real time awareness to users performing aspiration procedures, such as the removal of thrombus via an aspiration system 2. One skilled in the art will recognize that by knowing the real time condition of the aspiration system 2, the user is able to immediately make changes to the procedure in order to optimize results, increase safety for the patient and/or medical personnel, reduce costs (e.g. number of vacuum sources 6 required), and reduce procedure time (also a cost benefit). Because the user is typically performing multiple tasks during an aspiration procedure, the sensory aid provided by the aspiration monitoring system 48, 62, 78 allows the user to focus on these tasks without having to continually attempt to monitor conditions which are often difficult to visually monitor. The user may also modify and control the aspiration monitoring system 48, 62, 78 via an input 59 (
In some embodiments, alternate power sources may be used, for example, standard AC power with or without an AC/DC convertor; direct connection to existing equipment (e.g. vacuum pumps, etc.); solar power. The aspiration monitoring system 48, 62, 78 may be packaged sterile or may be resterilizable by techniques known by those skilled in the art. In some embodiments, flow or volume gauges may be used in conjunction with or instead of the pressure gauge 12, in order to determine, for example, a clog, or a change in the amount of vacuum.
Though aspiration of thrombus has been described in detail, the aspiration monitoring system 48, 62, 78 has utility in any aspiration application wherein heterogeneous media is being aspirated. This may include the aspiration of emboli (including not thrombotic emboli) from ducts, vessels, or cavities of the body, or even from solid or semi-solid portions of the body, including, but not limited to, portions of fat, breasts, and cancerous tissue.
In some embodiments, the aspiration system 2 is be provided to the user as a kit with all or several of the components described, while in other embodiments, only the aspiration monitoring system 48 is provided. Though discussion herein includes embodiments for aspiration of thrombus and blood, the definition of the word “fluid” should be understood throughout to comprise liquids and gases.
In some embodiments, an additional or alternate sensor may be used to monitor flow conditions for the notification of the user, including, but not limited to: a Doppler sensor, an infrared sensor, or a laser flow detection device. In some embodiments, an externally-attached Doppler sensor may be employed. In some embodiments, an infrared sensor or a laser flow detection device may be employed around the extension tubing 10.
This application claims the benefit of priority to U.S. Provisional Application No. 61/976,975, filed on Apr. 8, 2014, which is incorporated in its entirety by reference herein for all purposes. Priority is claimed pursuant to 35 U.S.C. §119.
Number | Name | Date | Kind |
---|---|---|---|
1114268 | Kells | Oct 1914 | A |
1148093 | Kells | Jul 1915 | A |
2804075 | Borden | Aug 1957 | A |
3429313 | Romanelli | Feb 1969 | A |
3693613 | Kelman | Sep 1972 | A |
3707967 | Kitrilakis et al. | Jan 1973 | A |
3916892 | Latham, Jr. | Nov 1975 | A |
3930505 | Wallach | Jan 1976 | A |
3955573 | Hansen et al. | May 1976 | A |
4299221 | Phillips et al. | Nov 1981 | A |
4465470 | Kelman | Aug 1984 | A |
4574812 | Arkans | Mar 1986 | A |
4638539 | Palmer | Jan 1987 | A |
4690672 | Veltrup | Sep 1987 | A |
4832685 | Haines | May 1989 | A |
4898574 | Uchiyama et al. | Feb 1990 | A |
4998919 | Schnepp-Pesch | Mar 1991 | A |
5057098 | Zelman | Oct 1991 | A |
5064428 | Cope et al. | Nov 1991 | A |
5073164 | Hollister et al. | Dec 1991 | A |
5125893 | Dryden | Jun 1992 | A |
5135482 | Neracher | Aug 1992 | A |
5197951 | Mahurkar et al. | Mar 1993 | A |
5234407 | Teirstein et al. | Aug 1993 | A |
5248297 | Takase | Sep 1993 | A |
5273047 | Tripp et al. | Dec 1993 | A |
5318518 | Plechinger et al. | Jun 1994 | A |
5322504 | Doherty et al. | Jun 1994 | A |
5342293 | Zanger | Aug 1994 | A |
5368555 | Sussman et al. | Nov 1994 | A |
5385562 | Adams et al. | Jan 1995 | A |
5395315 | Griep | Mar 1995 | A |
5419772 | Teitz et al. | May 1995 | A |
5486183 | Middleman et al. | Jan 1996 | A |
5490837 | Blaeser et al. | Feb 1996 | A |
5496267 | Drasler et al. | Mar 1996 | A |
5527274 | Zakko | Jun 1996 | A |
5536242 | Willard et al. | Jul 1996 | A |
5581038 | Lampropoulos et al. | Dec 1996 | A |
5606968 | Mang | Mar 1997 | A |
5624394 | Barnitz et al. | Apr 1997 | A |
5713849 | Bosma et al. | Feb 1998 | A |
5713851 | Boudewijn et al. | Feb 1998 | A |
5730717 | Gelbfish | Mar 1998 | A |
5772674 | Nakhjavan | Jun 1998 | A |
5795322 | Boudewijn | Aug 1998 | A |
5827229 | Auth et al. | Oct 1998 | A |
5843022 | Willard et al. | Dec 1998 | A |
5885244 | Leone et al. | Mar 1999 | A |
5910252 | Truitt et al. | Jun 1999 | A |
5916192 | Nita et al. | Jun 1999 | A |
5989210 | Morris et al. | Nov 1999 | A |
6019728 | Iwata et al. | Feb 2000 | A |
6022336 | Zadno-Azizi et al. | Feb 2000 | A |
6096001 | Drasler et al. | Aug 2000 | A |
6129697 | Drasler et al. | Oct 2000 | A |
6129698 | Beck | Oct 2000 | A |
6146396 | Kónya et al. | Nov 2000 | A |
6190357 | Ferrari et al. | Feb 2001 | B1 |
6196989 | Padget et al. | Mar 2001 | B1 |
6224570 | Le et al. | May 2001 | B1 |
6258061 | Drasler et al. | Jul 2001 | B1 |
6283719 | Frantz et al. | Sep 2001 | B1 |
6293960 | Ken | Sep 2001 | B1 |
6375635 | Moutafis et al. | Apr 2002 | B1 |
6471683 | Drasler et al. | Oct 2002 | B2 |
6544209 | Drasler et al. | Apr 2003 | B1 |
6572578 | Blanchard | Jun 2003 | B1 |
6579270 | Sussman et al. | Jun 2003 | B2 |
6599271 | Easley | Jul 2003 | B1 |
6616679 | Khosravi et al. | Sep 2003 | B1 |
6635070 | Leeflang et al. | Oct 2003 | B2 |
6719717 | Johnson et al. | Apr 2004 | B1 |
6755803 | Le et al. | Jun 2004 | B1 |
6755812 | Peterson et al. | Jun 2004 | B2 |
6926726 | Drasler et al. | Aug 2005 | B2 |
6991625 | Gately et al. | Jan 2006 | B1 |
7008434 | Kurz et al. | Mar 2006 | B2 |
7044958 | Douk et al. | May 2006 | B2 |
7232452 | Adams et al. | Jun 2007 | B2 |
7481222 | Reissmann | Jan 2009 | B2 |
7591816 | Wang et al. | Sep 2009 | B2 |
7621886 | Burnett | Nov 2009 | B2 |
7666161 | Nash et al. | Feb 2010 | B2 |
7699804 | Barry et al. | Apr 2010 | B2 |
7717898 | Gately et al. | May 2010 | B2 |
7736355 | Itou et al. | Jun 2010 | B2 |
7753868 | Hoffa | Jul 2010 | B2 |
7753880 | Malackowski | Jul 2010 | B2 |
7776005 | Haggstrom et al. | Aug 2010 | B2 |
7798996 | Haddad et al. | Sep 2010 | B1 |
7798999 | Bailey et al. | Sep 2010 | B2 |
7806864 | Haddad et al. | Oct 2010 | B2 |
7833239 | Nash | Nov 2010 | B2 |
7846175 | Bonnette et al. | Dec 2010 | B2 |
7867192 | Bowman et al. | Jan 2011 | B2 |
7875004 | Yodfat et al. | Jan 2011 | B2 |
7879022 | Bonnette et al. | Feb 2011 | B2 |
7887510 | Karpowicz et al. | Feb 2011 | B2 |
7905710 | Wang et al. | Mar 2011 | B2 |
7914482 | Urich et al. | Mar 2011 | B2 |
7918654 | Adahan | Apr 2011 | B2 |
7918822 | Kumar et al. | Apr 2011 | B2 |
7918835 | Callahan et al. | Apr 2011 | B2 |
7935077 | Thor et al. | May 2011 | B2 |
7951073 | Freed | May 2011 | B2 |
7951112 | Patzer | May 2011 | B2 |
7981129 | Nash et al. | Jul 2011 | B2 |
7998114 | Lombardi | Aug 2011 | B2 |
8007490 | Schaeffer et al. | Aug 2011 | B2 |
8012766 | Graham | Sep 2011 | B2 |
8034018 | Lutwyche | Oct 2011 | B2 |
8062246 | Moutafis et al. | Nov 2011 | B2 |
8062257 | Moberg et al. | Nov 2011 | B2 |
8065096 | Moberg et al. | Nov 2011 | B2 |
8066677 | Lunn et al. | Nov 2011 | B2 |
8075546 | Carlisle et al. | Dec 2011 | B2 |
8140146 | Kim et al. | Mar 2012 | B2 |
8152782 | Jang et al. | Apr 2012 | B2 |
8152951 | Zawacki et al. | Apr 2012 | B2 |
8157787 | Nash et al. | Apr 2012 | B2 |
8162877 | Bonnette et al. | Apr 2012 | B2 |
8177739 | Cartledge et al. | May 2012 | B2 |
8182462 | Istoc et al. | May 2012 | B2 |
8187228 | Bikovsky | May 2012 | B2 |
8202243 | Morgan | Jun 2012 | B2 |
8209060 | Ledford | Jun 2012 | B2 |
8246573 | Ali et al. | Aug 2012 | B2 |
8246580 | Hopkins et al. | Aug 2012 | B2 |
8257298 | Hamboly | Sep 2012 | B2 |
8257343 | Chan et al. | Sep 2012 | B2 |
8262645 | Bagwell et al. | Sep 2012 | B2 |
8267893 | Moberg et al. | Sep 2012 | B2 |
8287485 | Kimura et al. | Oct 2012 | B2 |
8291337 | Gannin et al. | Oct 2012 | B2 |
8292841 | Gregersen | Oct 2012 | B2 |
8317739 | Kuebler | Nov 2012 | B2 |
8317770 | Miesel et al. | Nov 2012 | B2 |
8317773 | Appling et al. | Nov 2012 | B2 |
8317786 | Dahla et al. | Nov 2012 | B2 |
8323268 | Ring et al. | Dec 2012 | B2 |
8337175 | Dion et al. | Dec 2012 | B2 |
8343131 | Vinten-Johansen | Jan 2013 | B2 |
8348896 | Wagner | Jan 2013 | B2 |
8353858 | Kozak et al. | Jan 2013 | B2 |
8353860 | Boulais et al. | Jan 2013 | B2 |
8372038 | Urich et al. | Feb 2013 | B2 |
8398581 | Panotopoulos | Mar 2013 | B2 |
8398582 | Gordon et al. | Mar 2013 | B2 |
8414521 | Baker et al. | Apr 2013 | B2 |
8414522 | Kamen et al. | Apr 2013 | B2 |
8419709 | Haddad et al. | Apr 2013 | B2 |
8425458 | Scopton | Apr 2013 | B2 |
8430837 | Jenson et al. | Apr 2013 | B2 |
8430861 | Schwartz et al. | Apr 2013 | B2 |
8439876 | Spohn et al. | May 2013 | B2 |
8454557 | Qi et al. | Jun 2013 | B1 |
8465456 | Stivland | Jun 2013 | B2 |
8465867 | Kim | Jun 2013 | B2 |
8483980 | Moberg et al. | Jul 2013 | B2 |
8491523 | Thor et al. | Jul 2013 | B2 |
8506537 | Torstensen et al. | Aug 2013 | B2 |
8523801 | Nash et al. | Sep 2013 | B2 |
8562555 | MacMahon et al. | Oct 2013 | B2 |
8597238 | Bonnette et al. | Dec 2013 | B2 |
8608699 | Blomquist | Dec 2013 | B2 |
8613618 | Brokx | Dec 2013 | B2 |
8613724 | Lanier, Jr. et al. | Dec 2013 | B2 |
8617110 | Moberg et al. | Dec 2013 | B2 |
8617127 | Woolston et al. | Dec 2013 | B2 |
8623039 | Seto et al. | Jan 2014 | B2 |
8641671 | Michaud et al. | Feb 2014 | B2 |
8647294 | Bonnette et al. | Feb 2014 | B2 |
8652086 | Gerg et al. | Feb 2014 | B2 |
8657777 | Kozak et al. | Feb 2014 | B2 |
8657785 | Torrance et al. | Feb 2014 | B2 |
8668464 | Kensy et al. | Mar 2014 | B2 |
8668665 | Gerg et al. | Mar 2014 | B2 |
8670836 | Aeschlimann et al. | Mar 2014 | B2 |
8672876 | Jacobson et al. | Mar 2014 | B2 |
8681010 | Moberg et al. | Mar 2014 | B2 |
20010051811 | Bonnette et al. | Dec 2001 | A1 |
20020068895 | Beck | Jun 2002 | A1 |
20020133114 | Itoh et al. | Sep 2002 | A1 |
20020138095 | Mazzocchi et al. | Sep 2002 | A1 |
20020165575 | Saleh | Nov 2002 | A1 |
20020173819 | Leeflang et al. | Nov 2002 | A1 |
20030032918 | Quinn | Feb 2003 | A1 |
20030069549 | MacMahon et al. | Apr 2003 | A1 |
20030088209 | Chiu et al. | May 2003 | A1 |
20030144688 | Brady et al. | Jul 2003 | A1 |
20030216760 | Welch et al. | Nov 2003 | A1 |
20030220556 | Porat et al. | Nov 2003 | A1 |
20030236533 | Wilson et al. | Dec 2003 | A1 |
20040049225 | Denison | Mar 2004 | A1 |
20040087988 | Heitzmann et al. | May 2004 | A1 |
20040147871 | Burnett | Jul 2004 | A1 |
20040158136 | Gough et al. | Aug 2004 | A1 |
20040167463 | Zawacki | Aug 2004 | A1 |
20040193046 | Nash et al. | Sep 2004 | A1 |
20040199201 | Kellett et al. | Oct 2004 | A1 |
20040243157 | Connor et al. | Dec 2004 | A1 |
20050065426 | Porat et al. | Mar 2005 | A1 |
20050102165 | Oshita et al. | May 2005 | A1 |
20050159716 | Kobayashi et al. | Jul 2005 | A1 |
20050196748 | Ericson | Sep 2005 | A1 |
20050240146 | Nash et al. | Oct 2005 | A1 |
20060009785 | Maitland et al. | Jan 2006 | A1 |
20060063973 | Makower et al. | Mar 2006 | A1 |
20060064123 | Bonnette et al. | Mar 2006 | A1 |
20060142630 | Meretei | Jun 2006 | A1 |
20070073233 | Thor et al. | Mar 2007 | A1 |
20070078438 | Okada | Apr 2007 | A1 |
20070197956 | Le et al. | Aug 2007 | A1 |
20070225739 | Pintor et al. | Sep 2007 | A1 |
20080009784 | Leedle et al. | Jan 2008 | A1 |
20080097339 | Ranchod et al. | Apr 2008 | A1 |
20080097563 | Petrie et al. | Apr 2008 | A1 |
20080195139 | Donald et al. | Aug 2008 | A1 |
20080249501 | Yamasaki | Oct 2008 | A1 |
20080255596 | Jenson et al. | Oct 2008 | A1 |
20080294181 | Wensel et al. | Nov 2008 | A1 |
20080306465 | Bailey et al. | Dec 2008 | A1 |
20080319376 | Wilcox et al. | Dec 2008 | A1 |
20090054825 | Melsheimer et al. | Feb 2009 | A1 |
20090105690 | Schaeffer et al. | Apr 2009 | A1 |
20090157057 | Ferren et al. | Jun 2009 | A1 |
20090292212 | Ferren et al. | Nov 2009 | A1 |
20100030186 | Stivland | Feb 2010 | A1 |
20100094201 | Mallaby | Apr 2010 | A1 |
20100204672 | Lockhart et al. | Aug 2010 | A1 |
20100217276 | Garrison et al. | Aug 2010 | A1 |
20100274191 | Ting | Oct 2010 | A1 |
20110106019 | Bagwell et al. | May 2011 | A1 |
20110160683 | Pinotti Barbosa et al. | Jun 2011 | A1 |
20120059340 | Larsson | Mar 2012 | A1 |
20120123509 | Merrill et al. | May 2012 | A1 |
20120130415 | Tal et al. | May 2012 | A1 |
20120259265 | Salehi et al. | Oct 2012 | A1 |
20120289910 | Shtul et al. | Nov 2012 | A1 |
20120291811 | Dabney et al. | Nov 2012 | A1 |
20130190701 | Kirn | Jul 2013 | A1 |
20130267891 | Malhi et al. | Oct 2013 | A1 |
20130310845 | Thor et al. | Nov 2013 | A1 |
20140005699 | Bonnette et al. | Jan 2014 | A1 |
20140147246 | Chappel et al. | May 2014 | A1 |
20140155931 | Bose et al. | Jun 2014 | A1 |
20140276920 | Hendrick at al | Sep 2014 | A1 |
20140309589 | Momose et al. | Oct 2014 | A1 |
20140323906 | Peatfield et al. | Oct 2014 | A1 |
Number | Date | Country |
---|---|---|
3715418 | Nov 1987 | DE |
806213 | Nov 1997 | EP |
726466 | Apr 2002 | EP |
1488748 | Dec 2004 | EP |
WO9005493 | May 1990 | WO |
WO9601079 | Jan 1996 | WO |
WO9635469 | Nov 1996 | WO |
WO9918850 | Apr 1999 | WO |
WO0137916 | May 2001 | WO |
WO2004100772 | Nov 2004 | WO |
WO2007143633 | Dec 2007 | WO |
WO2008097993 | Aug 2008 | WO |
Entry |
---|
PCT International Search Report and Written Opinion for PCT/US2015/024773, Applicant Incuvate, LLC, Forms PCT/ISA/220, 210, and 237 dated Jul. 8, 2015 (10 pages). |
“Comparison of Dimensions and Aspiration Rate of the Pronto V3, Pronto LP, Export XT, Export AP, Fetch, Xtract, Diver C.E. and QuickCat Catheter”, Vascular Solutions, Inc., downloaded from internet Oct. 22, 2014. |
Frölich, G., Meier, P., White, S., Yellon, D., Hausenloy, D., “Myocardial reperfusion injury: looking beyond primary PCI”, European Heart Journal Jun. 2013, pp. 1714-1722, vol. 34, No. 23, Elsevier, Amsterdam, The Netherlands. |
Gousios, A. Shearn, M, “Effect of Intravenous Heparin on Human Blood Viscosity” Circulation, Dec. 1959, pp. 1063-1066, vol. 20, American Heart Association, Dallas, USA. |
“Infusion Liquid Flow Sensors—Safe, Precise and Reliable”, Sensirion, downloaded from internet Apr. 3, 2015. |
Parikh, A., Ali, F., “Novel Use of GuideLiner Catheter to Perform Aspiration Thrombectomy in a Saphenous Vein Graft” Cath Lab Digest, Oct. 2013, downloaded from Internet Oct. 22, 2014. |
Prasad, A., Stone, G., Holmes, D., Gersh, B., Peperfusion Injury, Microvascular Dysfunction, and Carioprotection: The “Dark Side” of Reperfusion, Circulation, Nov. 24, 2009, pp. 2105-2112, vol. 120, American Heart Association, Dallas, USA. |
Rodriquez, R., Condé-Green, A., “Quantification of Negative Pressures Generated by Syringes of Different Calibers Used for Liposuction”, Plastic & Reconstructive Surgery, Aug. 2012, pp. 383e-384e. vol. 130, No. 2, Lippicott Williams & Wilkins, Philadelphia, USA. |
Stys, A., Stys, T., Rajpurohit, N., Khan, M. “A Novel Application of GuideLiner Catheter for Thrombectomy in Acute Myocardial Infarction: A Case Series”, Journal of Invasive cardiology, Nov. 2013, pp. 620-624, vol. 25, No. 11, King of Prussia, USA. |
“Guidion”, IMDS, downloaded from internet Jun. 29, 2015, http://www.imds.nl/our—product/guidion/. |
PCT International Search Report and Written Opinion for PCT/US2015/024569, Applicant Incuvate, LLC, Forms PCT/ISA/220, 210, and 237 dated Jun. 29, 2015 (14 pages). |
Meritrans, Merit Medical Systems, Inc., 400545002/B ID 120606, Date unknown (2 pages). |
Merit Mentor Simulator/Tester Instructions for Use Merit Medical Systems, Inc, 460101002 ID 062696, Date unknown (12 pages). |
Number | Date | Country | |
---|---|---|---|
20150283309 A1 | Oct 2015 | US |
Number | Date | Country | |
---|---|---|---|
61976975 | Apr 2014 | US |